Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy
作者： J. Shustik , M. Quinn , J.M. Connors , R.D. Gascoyne , B. Skinnider
关键词:
摘要: … To date, no studies have demonstrated a difference in outcome between FL3A and FL3B, … In our study, no difference in either OS or DSS was noted, although significantly fewer patients …
annalsofoncology.org
oup.com
paperity.org
oxfordjournals.org参考文章(24)
J. Rodriguez, P. McLaughlin, F.B. Hagemeister, L. Fayad, M.A. Rodriguez, M. Santiago, M. Hess, J. Romaguera, F. Cabanillas, Follicular Large Cell Lymphoma: An Aggressive Lymphoma That Often Presents With Favorable Prognostic Features Blood. ,vol. 93, pp. 2202- 2207 ,(1999) , 10.1182/BLOOD.V93.7.2202
Thomas P. Miller, Michael LeBlanc, Thomas M. Grogan, Richard I. Fisher, FOLLICULAR LYMPHOMAS:: Do Histologic Subtypes Predict Outcome? Hematology-oncology Clinics of North America. ,vol. 11, pp. 893- 900 ,(1997) , 10.1016/S0889-8588(05)70468-8
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Matthew T. Karafa, Brad Pohlman, Eric D. Hsi, Robert Coupland, John Hill, Gerard Lozanski, Imran Mirza, A Clinicopathologic Evaluation of Follicular Lymphoma Grade 3A Versus Grade 3B Reveals No Survival Differences Archives of Pathology & Laboratory Medicine. ,vol. 128, pp. 863- 868 ,(2004) , 10.1043/1543-2165(2004)128<863:ACEOFL>2.0.CO;2
J R Anderson, J M Vose, P J Bierman, D D Weisenberger, W G Sanger, J Pierson, M Bast, J O Armitage, Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group Journal of Clinical Oncology. ,vol. 11, pp. 218- 224 ,(1993) , 10.1200/JCO.1993.11.2.218
D Wendum, C Sebban, P Gaulard, B Coiffier, H Tilly, D Cazals, A Boehn, R O Casasnovas, R Bouabdallah, J Jaubert, A Ferrant, J Diebold, A de Mascarel, C Gisselbrecht, Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology. ,vol. 15, pp. 1654- 1663 ,(1997) , 10.1200/JCO.1997.15.4.1654
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Tiemo Katzenberger, German Ott, Thomas Klein, Jörg Kalla, Hans Konrad Müller-Hermelink, M. Michaela Ott, Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. American Journal of Pathology. ,vol. 165, pp. 481- 490 ,(2004) , 10.1016/S0002-9440(10)63313-5
I Chau, R Jones, D Cunningham, A Wotherspoon, N Maisey, A R Norman, P Jain, L Bishop, A Horwich, D Catovsky, Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? British Journal of Cancer. ,vol. 89, pp. 36- 42 ,(2003) , 10.1038/SJ.BJC.6601006
A.K. Ganti, D.D. Weisenburger, L.M. Smith, C.P. Hans, R.G. Bociek, P.J. Bierman, J.M. Vose, J.O. Armitage, Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. Annals of Oncology. ,vol. 17, pp. 920- 927 ,(2006) , 10.1093/ANNONC/MDL039